Immunotherapy for rectal carcinoma: Some stimulating data but still a long way to clinical evidence
- PMID: 27721056
- DOI: 10.1016/j.ejca.2016.09.003
Immunotherapy for rectal carcinoma: Some stimulating data but still a long way to clinical evidence
Comment on
-
PD-L1 is upregulated by radiochemotherapy in rectal adenocarcinoma patients and associated with a favourable prognosis.Eur J Cancer. 2016 Sep;65:52-60. doi: 10.1016/j.ejca.2016.06.015. Epub 2016 Jul 25. Eur J Cancer. 2016. PMID: 27468145
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
